City Therapeutics
Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas
$99.5MSeries B
Role not disclosedLoading investors…
Activity from announced rounds
Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas
Pitching Sofinnova Investments? Send the deck from a free RoundOS data room and see which pages they read.